Genomtec S.A.
GMT.WA · WSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | PLN 104 | PLN 101 | PLN 117 | PLN 105 |
| - Cash | PLN 7 | PLN 10 | PLN 14 | PLN 7 |
| + Debt | PLN 2 | PLN 2 | PLN 3 | PLN 3 |
| Enterprise Value | PLN 99 | PLN 93 | PLN 106 | PLN 101 |
| Revenue | PLN 0 | PLN 0 | PLN 0 | PLN 0 |
| % Growth | -33.3% | 20% | – | – |
| Gross Profit | -PLN 6 | -PLN 3 | -PLN 1 | PLN 0 |
| % Margin | -143,250% | -51,083.3% | -21,840% | – |
| EBITDA | -PLN 2 | -PLN 2 | -PLN 3 | -PLN 1 |
| % Margin | -46,275% | -40,616.7% | -50,300% | – |
| Net Income | -PLN 3 | -PLN 3 | -PLN 3 | -PLN 2 |
| % Margin | -64,300% | -55,833.3% | -64,100% | – |
| EPS Diluted | -0.17 | -0.23 | -0.22 | -0.14 |
| % Growth | 26.1% | -4.5% | -57.1% | – |
| Operating Cash Flow | -PLN 2 | -PLN 3 | -PLN 3 | PLN 1 |
| Capital Expenditures | -PLN 0 | -PLN 0 | PLN 0 | -PLN 0 |
| Free Cash Flow | -PLN 2 | -PLN 3 | -PLN 3 | PLN 1 |